Loading clinical trials...
Loading clinical trials...
NICO - CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer
Conditions
Interventions
Nivolumab, Surgery, Radiotherapy
Nivolumab, Surgery, Chemoradiotherapy
Locations
1
United Kingdom
Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, United Kingdom
Start Date
May 10, 2019
Primary Completion Date
February 24, 2025
Completion Date
February 24, 2025
Last Updated
February 25, 2025
NCT06030440
NCT07203911
NCT04191460
NCT03370276
NCT06086925
NCT05608369
Lead Sponsor
The Clatterbridge Cancer Centre NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions